- Home
- GOSS vs IVR Comparison
GOSS vs IVR Comparison
Compare GOSS & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- IVR
- Stock Information
- Founded
- GOSS 2015
- IVR 2008
- Country
- GOSS United States
- IVR United States
- Employees
- GOSS N/A
- IVR N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- IVR Real Estate Investment Trusts
- Sector
- GOSS Health Care
- IVR Real Estate
- Exchange
- GOSS Nasdaq
- IVR Nasdaq
- Market Cap
- GOSS 585.9M
- IVR 494.7M
- IPO Year
- GOSS 2019
- IVR 2009
- Fundamental
- Price
- GOSS $2.41
- IVR $7.26
- Analyst Decision
- GOSS Strong Buy
- IVR Hold
- Analyst Count
- GOSS 6
- IVR 2
- Target Price
- GOSS $8.60
- IVR $7.50
- AVG Volume (30 Days)
- GOSS 3.7M
- IVR 2.0M
- Earning Date
- GOSS 11-06-2025
- IVR 11-04-2025
- Dividend Yield
- GOSS N/A
- IVR 18.73%
- EPS Growth
- GOSS N/A
- IVR N/A
- EPS
- GOSS N/A
- IVR 0.32
- Revenue
- GOSS $40,237,000.00
- IVR $59,701,000.00
- Revenue This Year
- GOSS N/A
- IVR $273.10
- Revenue Next Year
- GOSS $34.10
- IVR $0.75
- P/E Ratio
- GOSS N/A
- IVR $22.88
- Revenue Growth
- GOSS N/A
- IVR 1793.56
- 52 Week Low
- GOSS $0.66
- IVR $5.86
- 52 Week High
- GOSS $3.60
- IVR $9.06
- Technical
- Relative Strength Index (RSI)
- GOSS 44.51
- IVR 39.55
- Support Level
- GOSS $2.25
- IVR $7.15
- Resistance Level
- GOSS $2.61
- IVR $7.67
- Average True Range (ATR)
- GOSS 0.18
- IVR 0.17
- MACD
- GOSS -0.05
- IVR -0.03
- Stochastic Oscillator
- GOSS 24.58
- IVR 15.61
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.